Skip to content

Abivax

  • About Us
    • Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Overview
    • Publications
  • Pipeline
    • Overview
    • Patients
    • ABX464 for UC
    • ABX464 for Crohn’s
    • ABX464 for RA
    • ABX464 for COVID-19
    • ABX464 for HIV
    • ABX196 for HCC
  • News & Events
    • Press Releases
    • Press Coverage
    • Upcoming Events
  • Investors
    • Overview
    • Share Price
    • Investor Documents
    • Annual General Meeting
  • Contact Us
Search
  • EN
  • FR
  • DE

Investors

Investor Documents

  • Half-Year Report For Liquidity Contract - December 31, 2020

    January 21, 2021
  • Number of Shares and Vote Rights - December 2020

    January 21, 2021
  • Number of Shares and Vote Rights - November 2020

    December 22, 2020
  • Number of Shares and Vote Rights - October 2020

    November 19, 2020
  • Number of Shares and Vote Rights - September 2020

    October 20, 2020
  • Half-Year Financial Report 2020

    September 30, 2020
  • Number of Shares and Vote Rights - August 2020

    September 15, 2020
  • Number of Shares and Vote Rights - July 2020

    September 2, 2020
  • 1
  • 2
  • 3
  • …
  • 12

Investor Contact

Chris Maggos LifeSci Advisors Chris@lifesciadvisors.com +41 79 367 6254
© 2021 All rights reserved by ABIVAX | Website created by DIGITAL VALLEE Privacy and Terms of Use
  • About Us
    • Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Overview
    • Publications
  • Pipeline
    • ABX464 for UC
    • ABX464 for HIV
    • ABX196 for HCC
    • ABX544 for Ebola Virus
  • News & Events
    • Press Releases
    • Press Coverage
    • Upcoming Events
  • Investors
    • Share Profile
    • Share Price
    • Investor Documents
    • Analysts
    • Annual General Meeting
    • UEG Week 2019
Contact Us
  • Follow us on Twitter
  • Follow us on LinkedIn
  • Follow us on YouTube
  • Follow us on Google+